-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WwtcH19uIZ8d8HsfwffsXGmJS1bjkOsh++78BmSeVCODXhwmhHB7lYqwAMz2bODi H4ddXIH7tKxqKr+UMpX5Uw== 0000950117-04-000760.txt : 20040225 0000950117-04-000760.hdr.sgml : 20040225 20040224182502 ACCESSION NUMBER: 0000950117-04-000760 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040224 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20040225 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BECTON DICKINSON & CO CENTRAL INDEX KEY: 0000010795 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 220760120 STATE OF INCORPORATION: NJ FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-04802 FILM NUMBER: 04625786 BUSINESS ADDRESS: STREET 1: ONE BECTON DR CITY: FRANKLIN LAKES STATE: NJ ZIP: 07417-1880 BUSINESS PHONE: 2018476800 MAIL ADDRESS: STREET 1: ONE BECTON DR CITY: FRANKLIN LAKE STATE: NJ ZIP: 07417 8-K 1 a37140.txt BECTON, DICKINSON & COMPANY SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 24, 2004 ----------------- BECTON, DICKINSON AND COMPANY - ------------------------------------------------------------------------------- (Exact name of registrant as specified in its charter) New Jersey 001-4802 22-0760120 - ------------------------------------------------------------------------------- (State or other juris- (Commission (IRS Employer Iden- diction of incorporation) File Number) tification Number) 1 Becton Drive, Franklin Lakes, New Jersey 07417-1880 - ------------------------------------------------------------------------------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (201) 847-6800 -------------- N/A - ------------------------------------------------------------------------------- (Former name or former addresses if changed since last report.) Item 9. Regulation FD Disclosure. The following statement is being furnished by the Company under the provisions of Regulation FD: On February 24, 2004, Vincent A. Forlenza, President - BD Biosciences of Becton, Dickinson and Company ("BD"), exercised stock options for 97,612 BD shares and sold the shares acquired upon exercise. These options were granted in 1996 and were due to expire in January 2006. In addition, Mr. Forlenza purchased 7,613 shares of BD in connection with the exercise of additional stock options. As a result of these transactions, Mr. Forlenza's beneficial ownership of BD shares (excluding stock options) has increased to 47,632 shares, and his beneficial ownership continues to be in excess of the requirements under BD's share ownership guidelines, which require Mr. Forlenza to own shares equal in value to at least three times his salary. The transactions announced today are part of Mr. Forlenza's financial strategy of asset diversification and liquidity. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BECTON, DICKINSON AND COMPANY (Registrant) By: /s/ Dean J. Paranicas -------------------------------- Dean J. Paranicas Vice President, Corporate Secretary and Public Policy Date: February 24, 2004 -----END PRIVACY-ENHANCED MESSAGE-----